Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Bidridistrogene xeboparvovec by Sarepta Therapeutics for Limb-Girdle Muscular Dystrophy: Likelihood of Approval
Bidridistrogene xeboparvovec is under clinical development by Sarepta Therapeutics and currently in Phase III for Limb-Girdle Muscular Dystrophy. According to...
Data Insights
Vesleteplirsen by Sarepta Therapeutics for Duchenne Muscular Dystrophy: Likelihood of Approval
Vesleteplirsen is under clinical development by Sarepta Therapeutics and currently in Phase II for Duchenne Muscular Dystrophy. According to GlobalData,...